Corrections, Department of; hepatitis C antiviral medication. (HB1651)
Introduced By
Del. Dawn Adams (D-Richmond) with support from co-patrons Del. Patrick Hope (D-Arlington), Del. Sam Rasoul (D-Roanoke), and Sen. Joe Morrissey (D-Richmond)
Progress
✓ |
Introduced |
✗ |
Passed Committee |
☐ |
Passed House |
☐ |
Passed Senate |
☐ |
Signed by Governor |
☐ |
Became Law |
Description
Department of Corrections; hepatitis C antiviral medication. Directs the Department of Corrections to issue a Request for Proposals to pharmaceutical manufacturers for the purchase of an unrestricted five-year supply of hepatitis C antiviral medication and any necessary ancillary services at an annual fixed rate. The bill requires the Department to report to the Governor and the General Assembly by November 30, 2020, and by November 30 during each year of the contract, regarding the status of the contract, whether the contract has lowered the Department's hepatitis C treatment costs, and inmate health outcomes resulting from the contract. Read the Bill »
Outcome
History
Date | Action |
---|---|
01/16/2020 | Committee |
01/16/2020 | Presented and ordered printed 20105572D |
01/16/2020 | Referred to Committee on Public Safety |
01/22/2020 | Assigned PS sub: Public Safety |
01/27/2020 | Impact statement from DPB (HB1651) |
01/30/2020 | Subcommittee recommends reporting (6-Y 2-N) |
01/30/2020 | Subcommittee recommends referring to Committee on Appropriations |
01/31/2020 | Reported from Public Safety (21-Y 1-N) (see vote tally) |
01/31/2020 | Referred to Committee on Appropriations |
02/11/2020 | Left in Appropriations |